Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.32 USD | -0.16% | -.--% | +14.29% |
08/05 | Crescita Therapeutics Q1 Loss Widens, Revenue Rises | MT |
08/05 | Crescita Therapeutics Brief: Q1 Revenue was $4.996 Million | MT |
Performance
1 day | -0.16% | ||
3 months | -16.88% | ||
6 months | +6.67% | ||
Current year | +14.29% | ||
1 year | -35.56% | ||
3 years | -51.25% | ||
5 years | -43.69% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Pharmaceuticals
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-0.16% | -.--% | +14.29% | -35.56% | 6.2M | ||
-1.50% | +3.41% | +30.38% | +74.49% | 684B | ||
+0.07% | +1.16% | +26.51% | +54.70% | 568B | ||
+0.04% | +0.43% | -4.36% | -6.88% | 361B | ||
-0.13% | +2.00% | +19.30% | +10.64% | 329B | ||
+0.22% | -1.86% | +3.73% | +9.66% | 284B | ||
+0.31% | +2.66% | +16.70% | +3.74% | 240B | ||
+1.97% | +4.94% | +8.78% | +0.41% | 208B | ||
+1.26% | +3.59% | -7.93% | -19.66% | 200B | ||
-0.87% | -0.37% | +7.68% | +33.52% | 166B | ||
-0.60% | +0.72% | -2.71% | -25.47% | 159B | ||
+1.23% | +3.32% | +5.09% | -4.53% | 127B | ||
+1.07% | +3.81% | +24.09% | +24.55% | 91.83B | ||
+2.14% | +1.82% | -18.58% | -16.19% | 82.18B | ||
+3.60% | -2.13% | +39.08% | +19.27% | 66.22B | ||
-.--% | +1.73% | - | - | 63.66B | ||
Average | +0.54% | +1.50% | +10.80% | +8.18% | ||
Weighted average by Cap. | +0.06% | +1.38% | +14.21% | +24.11% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | +14.29% | ||
2023 | -41.72% | ||
2022 | -5.37% | ||
2021 | -6.76% | ||
2020 | -27.05% | ||
2019 | +105.87% | ||
2018 | -16.63% | ||
2017 | -50.35% | ||
2016 | -24.66% |
- Stock Market
- Equities
- CTX Stock
- CRRTF Stock
- Quotes Crescita Therapeutics Inc.